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Argemone mexicana is a member of the Papaveraceae family of plants
that has been used for centuries in traditional medicine by indigenous
communities in Mexico and the United States. Through a collaborative
project, we have explored separation of key components of the seeds
and leaves of this plant to isolate the source of their biological activity.
We have already identified two key molecules which give this plant
anti-microbial properties against the gram-positive bacteria.
Furthermore, we have chemically modified one of these molecules to
observe variations on activity. We hope this leads to the discovery of
new antibiotic drugs.
Abstract Results Results
Evidence collected from LC-MS and
H-NMR data suggested fraction D was
Chelerythrine, and E was Berberine
(Figure 5). This was later confirmed
by TLC (Figure 6).
Conclusions
Bioactive extracts from the A. mexicana plant were separated into
individual components to identify the source of activity. This showed
Chelerythrine and Berberine to be responsible. We have also modified
berberine to determine ways to improve these properties.
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Introduction
Microbial infections, such as bacterial or fungal, account for a
persistent threat. This issue is compounded by the growing number of
drug-resistant microorganisms. In 2014, global deaths due
antimicrobial resistance was approximately 700,000 per year.1
Staphylococcus aureus is a common human pathogen, some strains of
which are resistant to multiple antibiotics.2
Plants naturally produce a robust supply of novel metabolic compounds
that can be used to treat a variety of human diseases.
Argemone mexicana has been reported to possess a wide-range of
biological activities, such as anticancer, antimicrobial, anthelmintic,
anti-inflammatory, anthelmintic, antidiabetic and antioxidant actions.3
The A. mexicana plant is native to the West Indies, but today it can also
be found in Mexico and throughout the Americas.4 It has been used in
traditional medicine for centuries. Our primary goal in the project is to
identify the components of this plant which are responsible for this
bioactivity. By identifying these plant-derived antimicrobials, we use
this to guide the development of new, unnatural compounds which can
pave the way for new drugs.
Prior to this work, the Orozco-Nunnelly lab studied extracting various
parts of the plant with solvents of different polarity. This work showed
that methanol extracts of the root showed the strongest activity against
S. aureus (Figure 1).
Figure 2: Prep-TLC was preformed on the crude methanol leaf extract of the A. mexicana. 
The bands showed different fluorescent compounds in the extract, which were use to 
identify the distinct components. 
As stated, the methanol extract of the A. mexicana showed the highest
level of bioactivity. To aid in the identification of the antimicrobial
components, the crude methanol extract was separated using various
chromatographic techniques, such as Pre-TLC (Figure 2).
The separated components, labeled fractions A-F, were examined using
the Kirby Bauer test to see zones of inhibition (Figure 3). It was
determined that fractions ‘D’ and ‘E’ showed the most activity.
Figure 3: S. aureus spread over agar. Diffusion disks impregnated with samples were 
placed on S. aureus, and after two days, zones of inhibition were measured.
To confirm the successful purification of
fractions D and E, these were compared by TLC
to the original root extract (Figure 4). These
isolated components were then analyzed by
Mass-spectrometry and H-NMR in an effort to
identify the molecules responsible for the
antibacterial activity.
Figure 4: Purity of the separations 
were evaluated using a TLC plate
Figure 5: Molecular structures for 
Chelerythrine (root-D) and Berberine (root-E) Figure 6: TLC plate for 
conformation of compounds
A commercial sample of Berberine was then chemically modified into
three derivatives, and these synthetic-analogs were tested to see how
these chemical modifications changed the bioactivity (Figure 7).
Figure 7: Berberine (1) was partially reduced to 2, fully reduced to 3, and reacted with an 
acetone enolate to give 4. S. aureus was treated with samples of 1-4, with 4 showing 
improved anti-microbial activity compared to the initial berberine. 
Figure 1: Preliminary tests showing antibacterial activity of the methanol-root extract 
